DK3217980T3 - Ciclopirox, ciclopirox-olamin, eller et ciclopirox-prodrug til anvendelse i behandlingen af blærekræft - Google Patents
Ciclopirox, ciclopirox-olamin, eller et ciclopirox-prodrug til anvendelse i behandlingen af blærekræft Download PDFInfo
- Publication number
- DK3217980T3 DK3217980T3 DK15859268.3T DK15859268T DK3217980T3 DK 3217980 T3 DK3217980 T3 DK 3217980T3 DK 15859268 T DK15859268 T DK 15859268T DK 3217980 T3 DK3217980 T3 DK 3217980T3
- Authority
- DK
- Denmark
- Prior art keywords
- ciclopirox
- olamin
- treatment
- product
- bladder cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462078069P | 2014-11-11 | 2014-11-11 | |
US201562134747P | 2015-03-18 | 2015-03-18 | |
PCT/US2015/059955 WO2016077346A1 (en) | 2014-11-11 | 2015-11-10 | Methods of bladder cancer treatment with ciclopirox, ciclopirox olamine, or a ciclopirox prodrug |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3217980T3 true DK3217980T3 (da) | 2020-12-07 |
Family
ID=55954945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15859268.3T DK3217980T3 (da) | 2014-11-11 | 2015-11-10 | Ciclopirox, ciclopirox-olamin, eller et ciclopirox-prodrug til anvendelse i behandlingen af blærekræft |
Country Status (11)
Country | Link |
---|---|
US (1) | US20170304329A1 (da) |
EP (1) | EP3217980B1 (da) |
JP (1) | JP2017533952A (da) |
CN (2) | CN116687941A (da) |
DK (1) | DK3217980T3 (da) |
ES (1) | ES2836208T3 (da) |
HR (1) | HRP20201893T1 (da) |
HU (1) | HUE052670T2 (da) |
PT (1) | PT3217980T (da) |
RS (1) | RS61222B1 (da) |
WO (1) | WO2016077346A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11753379B2 (en) | 2018-05-30 | 2023-09-12 | Clariant International Ltd | Process for forming 2-hydroxypyridine-1-oxide or derivatives thereof |
US20210251975A1 (en) * | 2018-08-23 | 2021-08-19 | Gwangju Institute Of Science And Technology | Use of ciclopirox for inhibiting hbv core assembly |
WO2021078937A1 (en) * | 2019-10-25 | 2021-04-29 | Deutsches Krebsforschungszentrum | Treatment of stat3 related diseases by iron chelators |
EP4193989A1 (en) | 2021-12-09 | 2023-06-14 | Atlas Molecular Pharma, S.L. | A formulation for an effective oral administration of ciclopirox with no adversal gasterointestinal toxicity |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033846A2 (en) | 1997-12-31 | 1999-07-08 | The University Of Kansas | Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof |
WO2004007676A2 (en) * | 2002-07-15 | 2004-01-22 | Combinatorx, Incorporated | Combination therapy for the treatment of neoplasms |
US20110212176A1 (en) | 2008-10-31 | 2011-09-01 | University Health Network | Ciclopirox and cytarabine for the treatment of leukemic disorders |
ES2573116T3 (es) | 2010-12-02 | 2016-06-06 | The University Of Kansas | Profármacos de 6-ciclohexil-1-hidroxi-4-metilpiridin-2(1H)-ona y sus derivados |
-
2015
- 2015-11-10 JP JP2017526594A patent/JP2017533952A/ja active Pending
- 2015-11-10 DK DK15859268.3T patent/DK3217980T3/da active
- 2015-11-10 HU HUE15859268A patent/HUE052670T2/hu unknown
- 2015-11-10 PT PT158592683T patent/PT3217980T/pt unknown
- 2015-11-10 EP EP15859268.3A patent/EP3217980B1/en active Active
- 2015-11-10 US US15/526,164 patent/US20170304329A1/en not_active Abandoned
- 2015-11-10 CN CN202310102470.8A patent/CN116687941A/zh active Pending
- 2015-11-10 ES ES15859268T patent/ES2836208T3/es active Active
- 2015-11-10 CN CN201580061284.8A patent/CN107206012A/zh active Pending
- 2015-11-10 RS RS20201438A patent/RS61222B1/sr unknown
- 2015-11-10 WO PCT/US2015/059955 patent/WO2016077346A1/en active Application Filing
-
2020
- 2020-11-27 HR HRP20201893TT patent/HRP20201893T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
ES2836208T3 (es) | 2021-06-24 |
EP3217980B1 (en) | 2020-10-14 |
HRP20201893T1 (hr) | 2021-02-05 |
CN116687941A (zh) | 2023-09-05 |
CN107206012A (zh) | 2017-09-26 |
US20170304329A1 (en) | 2017-10-26 |
EP3217980A4 (en) | 2018-05-02 |
RS61222B1 (sr) | 2021-01-29 |
JP2017533952A (ja) | 2017-11-16 |
EP3217980A1 (en) | 2017-09-20 |
WO2016077346A1 (en) | 2016-05-19 |
HUE052670T2 (hu) | 2021-05-28 |
PT3217980T (pt) | 2020-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3206715T3 (da) | Anvendelse af cannabidiol i behandling af tuberøs sklerosekompleks | |
DK3191144T3 (da) | Medicinsk forbinding | |
DK3154594T3 (da) | Fap-aktiverede, terapeutiske midler og anvendelser i forbindelser dermed | |
BR112017004332A2 (pt) | perfis. | |
BR112016027041A2 (pt) | Combinações farmacêuticas para tratamento do câncer | |
DK3456330T3 (da) | Cortexolon-17alpha-valerat til anvendelse ved behandling af tumorer | |
DK3302519T3 (da) | Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom | |
DK3374497T3 (da) | Modificerede makrofager til anvendelse i behandlingen af kræft | |
BR112017012358A2 (pt) | artigo absorvente. | |
IL249220B (en) | Use of Aribolin in cancer treatment | |
FR3025176B1 (fr) | Aile portante escamotable | |
GB201408673D0 (en) | Medicaments,uses and methods | |
DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
DK3125874T3 (da) | Et terapeutisk middel til anvendelse i behandlingen af infektioner | |
BR112016026078A2 (pt) | Produto absorvente | |
DK3217980T3 (da) | Ciclopirox, ciclopirox-olamin, eller et ciclopirox-prodrug til anvendelse i behandlingen af blærekræft | |
BR112016019480A2 (pt) | Cateter seguro | |
DK3795130T3 (da) | Terapiapparat. | |
KR20180084983A (ko) | 암의 치료를 위한 피리미도-피리미다지논의 용도 | |
ES1119705Y (es) | Tabla para rescate | |
ES1124632Y (es) | Tabla de Salvamento | |
FI10397U1 (fi) | Nosturiteline | |
ITUB20155450A1 (it) | Composizione per il trattamento delle dermatiti. | |
TH1601003435A (th) | อุปกรณ์สำหรับการผลิตวัตถุสำหรับการดูดซึม | |
UA31491S (uk) | Стіл |